missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ VEGFR2/KDR/Flk-1 Antibody (ramucirumab), Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28207-50ug
This item is not returnable.
View return policy
Description
VEGFR2/KDR/Flk-1 Monoclonal antibody specifically detects VEGFR2/KDR/Flk-1 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| VEGFR2/KDR/Flk-1 | |
| Monoclonal | |
| Unconjugated | |
| P35968 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| ramucirumab | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2 | |
| VEGFR2/ KDR/ CD309 | |
| 50 μg | |
| Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases | |
| 3791 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction